Search Results 601-610 of 18645 for hepatitis

1. A Study to Evaluate the Use of Nivolumab and Pomalidomide Combination for Relapsed/Refractory Primary Central Nervous System Lymphoma and Primary Vitreoretinal Lymphoma - Mayo Clinic

   Active hepatitis B or C with uncontrolled disease. NOTE: a detailed ... NOTE: a detailed assessment of hepatitis B/C medical history and risk factors must be done ...

2. NAFLD and NASH research update - Mayo Clinic

   Vargas, M.D., a gastroenterologist and hepatologist specializing in viral hepatitis and liver transplantation at Mayo Clinic's campus in Arizona. Dr. Vargas ...

3. Modified VR-CAP and Acalabrutinib as First Line Therapy for the Treatment of Transplant-Eligible Patients With Mantle Cell Lymphoma - Mayo Clinic

   * Active or chronic uncontrolled hepatitis B or hepatitis C infection. Patients with positive hepatitis B core antibody positive require negative polymerase ...

4. Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma - Mayo Clinic

   No active viral infection with human immunodeficiency virus (HIV), hepatitis B, or hepatitis C. Those who are seropositive (e.g., hepatitis B core antibody ...

5. Infectious Diseases A–Z: Should babies get their recommended vaccines at one time?

   Haemophilus influenzae type b; Hepatitis B (second dose); Polio · Pneumococcal · Rotavirus. Parents are encouraged to follow the Centers for Disease Control and ...

6. Living With Cancer: Protecting yourself from melanoma - Mayo Clinic News Network

   Here are some ideas that may help if you'd like to write about your personal experiences. Should you be tested for hepatitis? Beating Esophageal Cancer Odds to ...

7. Publications - Barry G. Rosser, Jr., M.D. - Mayo Clinic

   Hepatitis C recurrence is not associated with allograft steatosis within the first year after liver transplantation. Liver Transpl. 2004 May; 10(5):599-606.

8. Tipranavir (oral route) - Mayo Clinic

   Hyperlipidemia (high cholesterol or fats in the blood) or; Liver disease (eg, hepatitis B or C)—Use with caution. May make these conditions worse. Liver disease ...

9. Alternate Doses and Dosing Schedules of Belantamab Mafodotin for the Treatment of Triple-Class Recurrent and/or Refractory Multiple Myeloma - Mayo Clinic

   ... hepatitis B will be excluded unless the following criteria can be met: - If patient's serology shows hepatitis B virus core antibody (HbcAb)+ and hepatitis ...

10. Mayo Clinic Q&A podcast: Vaccines and kids - what you need to know about COVID-19, flu

    'Our goal is to achieve a world without viral hepatitis' · Mayo Clinic's president and CEO to reflect on evolution of individualized medicine. Related Articles.